SPOT X Y PI MW AC MAPPING METHODS PMF PEPTIDES AMINO ACID OD VOLUME PATHOLOGY LEVEL EXPRESSION COMMENT: SUBUNIT COMMENT: SPECIAL MISCELLANEOUS COMMENT: STRAIN 89 48 85 33,544 P02760 111 46 103 32,167 P02760 112 71 104 31,046 P02760 Im 769.468 (1.09); 824.448 (2.67); 1235.708 (3.17); 1312.129 (1.2); 2325.211 (5.14); TRYPSIN {private} 408 104 346 23,908 P02760 Co (S)RLDMoxDSIIAEVK(K),352-363; (S)SSLEAAIADAEQR(E),428-440 {private} 408 P02741 408 P13693 (R)SLDMoxDIAEVK(A),252-261 B=12, Z=13.7, S=3.7, H=0.3, G=11.8, T=5.2, Y=2.5 {private} 0.999 0.888 Increased During Reaction; Decreased During Emphysema Low in strain Homodimer (By similarity) Probal Signal E-1776 397 362 331 32,375 Q99TY2 Single Chain 397 P11111 397 P12345 PMF,MS/MS 1473.868 (7.11); 1491.913 (0.99); 2225.211 (5.14); TRYPSIN (S)SSLEAAIADAEQR(E),428-440 Hight expression in strain 465 382 385 27,200 Q99TY2 900 300 205 30,375 PMF,MS/MS 1413.868 (7.23); 1291.913 (3.99); 2221.211 (4.14); TRYPSIN (S)SSLEAAIASSLLEQR(E),326-340 901 113 24 49,999 PMF,MS/MS 1513.868 (7.23); 1391.913 (3.99); 2321.211 (4.14); TRYPSIN (S)AALEAAIASSLLEQR(E),336-350